BULL-CERTIFICATE STOP LOSS - RECORDATI INDUSTRIA CHIMICA E FARMA BULL-CERTIFICATE STOP LOSS - RECORDATI INDUSTRIA CHIMICA E FARMA Share Price
Certificat
P1FSG9
NLBNPIT1FSG9
| Market Closed - Borsa Italiana 21:04:59 14/06/2024 BST | ||
| 16.66 EUR | -4.69% |
|
| Current month | -4.14% | ||
| 1 month | -13.05% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 14/06/24 | 16.66 | -4.69% |
| 13/06/24 | 17.48 | -2.24% |
| 12/06/24 | 17.88 | +4.62% |
| 11/06/24 | 17.09 | -6.20% |
| 10/06/24 | 18.22 | -0.49% |
Real-time Borsa Italiana
Last update June 14, 2024 at 09:04 pm
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | 
BNP Paribas
|
| P1FSG9 | |
| ISIN | NLBNPIT1FSG9 |
| Date issued | 05/08/2022 |
| Strike | 31.61 € |
| Maturity | 19/12/2025 (552 Days) |
| Parity | 1 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 21.92 € |
|---|---|
| Lowest since issue | 5.48 € |
| Spread | 0.6 € |
| Spread % | 3.52% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
48.1
EUR
Average target price
52.64
EUR
Spread / Average Target
+9.44%
- Stock Market
- Certificates
- P1FSG9 Certificat